For some rare conditions (AMD is not considered one but Stargardt’s is), developing treatments for them is difficult because companies may not make money on them or recover the cost to develop them. In the US, the FDA provides funding for some of these…
From 2016
This is a follow-up to yesterday’s post about Sue’s 100th page (About Our Project).
Time Flies When You’re [not] Having Fun